SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU1
SMART Health Cards: Vaccination & Testing Implementation Guide
1.0.0 - STU1
SMART Health Cards: Vaccination & Testing Implementation Guide, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-shc-vaccination-ig/ and changes regularly. See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 4 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="immunization-all-cvx"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet immunization-all-cvx</b></p><a name="immunization-all-cvx"> </a><a name="hcimmunization-all-cvx"> </a><ul><li>Include these codes as defined in <a href="http://terminology.hl7.org/6.5.0/CodeSystem-CVX.html"><code>http://hl7.org/fhir/sid/cvx</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>54</td><td>adenovirus, type 4</td></tr><tr><td>55</td><td>adenovirus, type 7</td></tr><tr><td>82</td><td>adenovirus, unspecified formulation</td></tr><tr><td>24</td><td>Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis</td></tr><tr><td>19</td><td>BCG</td></tr><tr><td>27</td><td>botulinum antitoxin</td></tr><tr><td>26</td><td>cholera, unspecified formulation</td></tr><tr><td>29</td><td>CMVIG</td></tr><tr><td>56</td><td>dengue fever tetravalent</td></tr><tr><td>12</td><td>diphtheria antitoxin</td></tr><tr><td>28</td><td>DT (pediatric)</td></tr><tr><td>20</td><td>DTaP</td></tr><tr><td>106</td><td>DTaP, 5 pertussis antigens</td></tr><tr><td>107</td><td>DTaP, unspecified formulation</td></tr><tr><td>110</td><td>DTaP-Hep B-IPV</td></tr><tr><td>50</td><td>DTaP-Hib</td></tr><tr><td>120</td><td>DTaP-Hib-IPV</td></tr><tr><td>130</td><td>DTaP-IPV</td></tr><tr><td>22</td><td>DTP-Hib</td></tr><tr><td>102</td><td>DTP-Hib-Hep B</td></tr><tr><td>57</td><td>hantavirus</td></tr><tr><td>52</td><td>Hep A, adult</td></tr><tr><td>83</td><td>Hep A, ped/adol, 2 dose</td></tr><tr><td>84</td><td>Hep A, ped/adol, 3 dose</td></tr><tr><td>31</td><td>Hep A, pediatric, unspecified formulation</td></tr><tr><td>85</td><td>Hep A, unspecified formulation</td></tr><tr><td>104</td><td>Hep A-Hep B</td></tr><tr><td>30</td><td>HBIG</td></tr><tr><td>42</td><td>Hep B, adolescent/high risk infant</td></tr><tr><td>43</td><td>Hep B, adult</td></tr><tr><td>44</td><td>Hep B, high-dosage, dialysis or IC</td></tr><tr><td>45</td><td>Hep B, unspecified formulation</td></tr><tr><td>58</td><td>Hep C</td></tr><tr><td>59</td><td>Hep E</td></tr><tr><td>60</td><td>herpes simplex 2</td></tr><tr><td>46</td><td>Hib (PRP-D)</td></tr><tr><td>47</td><td>Hib (HbOC)</td></tr><tr><td>48</td><td>Hib (PRP-T)</td></tr><tr><td>49</td><td>Hib (PRP-OMP)</td></tr><tr><td>17</td><td>Hib, unspecified formulation</td></tr><tr><td>51</td><td>Hib-Hep B</td></tr><tr><td>61</td><td>HIV</td></tr><tr><td>118</td><td>HPV, bivalent</td></tr><tr><td>62</td><td>HPV, quadrivalent</td></tr><tr><td>86</td><td>IG</td></tr><tr><td>87</td><td>IGIV</td></tr><tr><td>14</td><td>IG, unspecified formulation</td></tr><tr><td>111</td><td>Influenza, live, trivalent, intranasal, PF</td></tr><tr><td>15</td><td>influenza, split (incl. purified surface antigen)</td></tr><tr><td>16</td><td>influenza, whole</td></tr><tr><td>88</td><td>influenza, unspecified formulation</td></tr><tr><td>123</td><td>influenza, H5N1-1203</td></tr><tr><td>10</td><td>IPV</td></tr><tr><td>89</td><td>polio, unspecified formulation</td></tr><tr><td>39</td><td>Japanese encephalitis SC</td></tr><tr><td>63</td><td>Junin virus</td></tr><tr><td>64</td><td>leishmaniasis</td></tr><tr><td>65</td><td>leprosy</td></tr><tr><td>66</td><td>Lyme disease</td></tr><tr><td>94</td><td>MMRV</td></tr><tr><td>67</td><td>malaria</td></tr><tr><td>68</td><td>melanoma</td></tr><tr><td>32</td><td>meningococcal MPSV4</td></tr><tr><td>103</td><td>meningococcal C conjugate</td></tr><tr><td>114</td><td>meningococcal MCV4P</td></tr><tr><td>108</td><td>meningococcal ACWY, unspecified formulation</td></tr><tr><td>69</td><td>parainfluenza-3</td></tr><tr><td>11</td><td>pertussis</td></tr><tr><td>23</td><td>plague</td></tr><tr><td>33</td><td>pneumococcal polysaccharide PPV23</td></tr><tr><td>100</td><td>pneumococcal conjugate PCV 7</td></tr><tr><td>109</td><td>pneumococcal, unspecified formulation</td></tr><tr><td>70</td><td>Q fever</td></tr><tr><td>18</td><td>rabies, intramuscular injection</td></tr><tr><td>40</td><td>rabies, intradermal injection</td></tr><tr><td>90</td><td>rabies, unspecified formulation</td></tr><tr><td>72</td><td>rheumatic fever</td></tr><tr><td>73</td><td>Rift Valley fever</td></tr><tr><td>34</td><td>RIG</td></tr><tr><td>119</td><td>rotavirus, monovalent</td></tr><tr><td>122</td><td>rotavirus, unspecified formulation</td></tr><tr><td>116</td><td>rotavirus, pentavalent</td></tr><tr><td>74</td><td>rotavirus, tetravalent</td></tr><tr><td>71</td><td>RSV-IGIV</td></tr><tr><td>93</td><td>RSV-MAb</td></tr><tr><td>38</td><td>rubella/mumps</td></tr><tr><td>76</td><td>Staphylococcus bacterio lysate</td></tr><tr><td>113</td><td>Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed</td></tr><tr><td>115</td><td>Tdap</td></tr><tr><td>35</td><td>tetanus toxoid, adsorbed</td></tr><tr><td>112</td><td>tetanus toxoid, unspecified formulation</td></tr><tr><td>77</td><td>Tick-borne encephalitis vaccine (non-US)</td></tr><tr><td>13</td><td>TIG</td></tr><tr><td>95</td><td>TST-OT tine test</td></tr><tr><td>96</td><td>TST-PPD intradermal</td></tr><tr><td>97</td><td>TST-PPD tine test</td></tr><tr><td>98</td><td>TST, unspecified formulation</td></tr><tr><td>78</td><td>tularemia vaccine</td></tr><tr><td>91</td><td>typhoid, unspecified formulation</td></tr><tr><td>25</td><td>typhoid, oral</td></tr><tr><td>41</td><td>typhoid, parenteral</td></tr><tr><td>53</td><td>typhoid, parenteral, AKD (U.S. military)</td></tr><tr><td>101</td><td>typhoid, ViCPs</td></tr><tr><td>75</td><td>Vaccinia (smallpox, mpox), live</td></tr><tr><td>105</td><td>vaccinia (smallpox) diluted</td></tr><tr><td>79</td><td>vaccinia immune globulin</td></tr><tr><td>21</td><td>varicella</td></tr><tr><td>81</td><td>VEE, inactivated</td></tr><tr><td>80</td><td>VEE, live</td></tr><tr><td>92</td><td>VEE, unspecified formulation</td></tr><tr><td>36</td><td>VZIG</td></tr><tr><td>117</td><td>VZIG (IND)</td></tr><tr><td>37</td><td>yellow fever live</td></tr><tr><td>121</td><td>zoster live</td></tr><tr><td>998</td><td>no vaccine administered</td></tr><tr><td>999</td><td>unknown</td></tr><tr><td>99</td><td>RESERVED - do not use</td></tr><tr><td>133</td><td>Pneumococcal conjugate PCV 13</td></tr><tr><td>134</td><td>Japanese Encephalitis IM</td></tr><tr><td>137</td><td>HPV, unspecified formulation</td></tr><tr><td>136</td><td>Meningococcal MCV4O</td></tr><tr><td>135</td><td>Influenza, high-dose, trivalent, PF</td></tr><tr><td>131</td><td>typhus, historical</td></tr><tr><td>132</td><td>DTaP-IPV-HIB-HEP B, historical</td></tr><tr><td>128</td><td>Novel Influenza-H1N1-09, all formulations</td></tr><tr><td>125</td><td>Novel Influenza-H1N1-09, nasal</td></tr><tr><td>126</td><td>Novel influenza-H1N1-09, preservative-free</td></tr><tr><td>127</td><td>Novel influenza-H1N1-09</td></tr><tr><td>138</td><td>Td (adult)</td></tr><tr><td>139</td><td>Td(adult) unspecified formulation</td></tr><tr><td>140</td><td>Influenza, split virus, trivalent, PF</td></tr><tr><td>129</td><td>Japanese Encephalitis, unspecified formulation</td></tr><tr><td>141</td><td>Influenza, split virus, trivalent, preservative</td></tr><tr><td>142</td><td>tetanus toxoid, not adsorbed</td></tr><tr><td>143</td><td>Adenovirus types 4 and 7</td></tr><tr><td>144</td><td>influenza, seasonal, intradermal, preservative free</td></tr><tr><td>145</td><td>RSV-MAb (new)</td></tr><tr><td>146</td><td>DTaP,IPV,Hib,HepB</td></tr><tr><td>147</td><td>meningococcal MCV4, unspecified formulation</td></tr><tr><td>148</td><td>Meningococcal C/Y-HIB PRP</td></tr><tr><td>149</td><td>Influenza, live, quadrivalent, intranasal</td></tr><tr><td>150</td><td>Influenza, split virus, quadrivalent, PF</td></tr><tr><td>151</td><td>influenza nasal, unspecified formulation</td></tr><tr><td>152</td><td>Pneumococcal Conjugate, unspecified formulation</td></tr><tr><td>153</td><td>Influenza, MDCK, trivalent, PF</td></tr><tr><td>154</td><td>Hep A, IG</td></tr><tr><td>155</td><td>Influenza, recombinant, trivalent, PF</td></tr><tr><td>156</td><td>Rho(D)-IG</td></tr><tr><td>157</td><td>Rho(D) -IG IM</td></tr><tr><td>158</td><td>Influenza, split virus, quadrivalent, preservative</td></tr><tr><td>159</td><td>Rho(D) - Unspecified formulation</td></tr><tr><td>160</td><td>Influenza A monovalent (H5N1), ADJUVANTED-2013</td></tr><tr><td>801</td><td>AS03 Adjuvant</td></tr><tr><td>161</td><td>Influenza, injectable,quadrivalent, preservative free, pediatric</td></tr><tr><td>162</td><td>meningococcal B, recombinant</td></tr><tr><td>163</td><td>meningococcal B, OMV</td></tr><tr><td>164</td><td>meningococcal B, unspecified</td></tr><tr><td>165</td><td>HPV9</td></tr><tr><td>166</td><td>influenza, intradermal, quadrivalent, preservative free</td></tr><tr><td>167</td><td>meningococcal, unknown serogroups</td></tr><tr><td>168</td><td>Influenza, adjuvanted, trivalent, PF</td></tr><tr><td>169</td><td>Hep A, live attenuated</td></tr><tr><td>170</td><td>DTAP/IPV/HIB - non-US</td></tr><tr><td>171</td><td>Influenza, MDCK, quadrivalent, PF</td></tr><tr><td>172</td><td>cholera, WC-rBS</td></tr><tr><td>173</td><td>cholera, BivWC</td></tr><tr><td>174</td><td>cholera, live attenuated</td></tr><tr><td>175</td><td>Rabies - IM Diploid cell culture</td></tr><tr><td>176</td><td>Rabies - IM fibroblast culture</td></tr><tr><td>177</td><td>PCV10</td></tr><tr><td>178</td><td>OPV bivalent</td></tr><tr><td>179</td><td>OPV ,monovalent, unspecified</td></tr><tr><td>180</td><td>tetanus immune globulin</td></tr><tr><td>181</td><td>anthrax immune globulin</td></tr><tr><td>182</td><td>OPV, Unspecified</td></tr><tr><td>183</td><td>Yellow fever vaccine live - alt</td></tr><tr><td>184</td><td>Yellow fever, unspecified</td></tr><tr><td>185</td><td>Influenza, recombinant, quadrivalent, PF</td></tr><tr><td>186</td><td>Influenza, MDCK, quadrivalent, preservative</td></tr><tr><td>187</td><td>zoster recombinant</td></tr><tr><td>188</td><td>zoster, unspecified formulation</td></tr><tr><td>189</td><td>HepB-CpG</td></tr><tr><td>190</td><td>Typhoid conjugate vaccine (TCV)</td></tr><tr><td>191</td><td>meningococcal A polysaccharide (non-US)</td></tr><tr><td>192</td><td>meningococcal AC polysaccharide (non-US)</td></tr><tr><td>193</td><td>Hep A-Hep B, pediatric/adolescent</td></tr><tr><td>194</td><td>Influenza, Southern Hemisphere</td></tr><tr><td>195</td><td>DT, IPV adsorbed</td></tr><tr><td>196</td><td>Td, adsorbed, preservative free, adult use, Lf unspecified</td></tr><tr><td>197</td><td>Influenza, high-dose, quadrivalent, PF</td></tr><tr><td>200</td><td>influenza, Southern Hemisphere, pediatric, preservative free</td></tr><tr><td>201</td><td>Influenza, Southern Hemisphere, quadrivalent, PF</td></tr><tr><td>202</td><td>influenza, Southern Hemisphere, quadrivalent, with preservative</td></tr><tr><td>198</td><td>DTP-hepB-Hib Pentavalent Non-US</td></tr><tr><td>203</td><td>meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)</td></tr><tr><td>205</td><td>Influenza, adjuvanted, quadrivalent, PF</td></tr><tr><td>206</td><td>Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection</td></tr><tr><td>207</td><td>COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose</td></tr><tr><td>208</td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose</td></tr><tr><td>213</td><td>SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED</td></tr><tr><td>210</td><td>COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL</td></tr><tr><td>212</td><td>COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL</td></tr><tr><td>204</td><td>Ebola Zaire vaccine, live, recombinant, 1mL dose</td></tr><tr><td>214</td><td>Ebola, unspecified</td></tr><tr><td>211</td><td>COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL</td></tr><tr><td>500</td><td>COVID-19 Non-US Vaccine, Product Unknown</td></tr><tr><td>501</td><td>COVID-19 IV Non-US Vaccine (QAZCOVID-IN)</td></tr><tr><td>502</td><td>COVID-19 IV Non-US Vaccine (COVAXIN)</td></tr><tr><td>503</td><td>COVID-19 LAV Non-US Vaccine (COVIVAC)</td></tr><tr><td>504</td><td>COVID-19 VVnr Non-US Vaccine (Sputnik Light)</td></tr><tr><td>505</td><td>COVID-19 VVnr Non-US Vaccine (Sputnik V)</td></tr><tr><td>506</td><td>COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology</td></tr><tr><td>507</td><td>COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)</td></tr><tr><td>508</td><td>COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)</td></tr><tr><td>509</td><td>COVID-19 PS Non-US Vaccine (EpiVacCorona)</td></tr><tr><td>510</td><td>COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)</td></tr><tr><td>511</td><td>COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)</td></tr><tr><td>215</td><td>Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF</td></tr><tr><td>216</td><td>Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF</td></tr><tr><td>219</td><td>COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose</td></tr><tr><td>217</td><td>COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose</td></tr><tr><td>218</td><td>COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose</td></tr><tr><td>220</td><td>HepB recombinant, 3-antigen, Al(OH)3</td></tr><tr><td>221</td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose</td></tr><tr><td>222</td><td>Tick-borne encephalitis, unspecified</td></tr><tr><td>223</td><td>Tick-borne encephalitis, inactivated, PF, 0.25mL</td></tr><tr><td>224</td><td>Tick-borne encephalitis, inactivated, PF, 0.5mL</td></tr><tr><td>225</td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL</td></tr><tr><td>226</td><td>COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL</td></tr><tr><td>512</td><td>SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)</td></tr><tr><td>513</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)</td></tr><tr><td>514</td><td>SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)</td></tr><tr><td>515</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)</td></tr><tr><td>516</td><td>COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)</td></tr><tr><td>517</td><td>SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)</td></tr><tr><td>227</td><td>COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose</td></tr><tr><td>228</td><td>COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose</td></tr><tr><td>229</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose</td></tr><tr><td>301</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose</td></tr><tr><td>300</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose</td></tr><tr><td>230</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL</td></tr><tr><td>518</td><td>COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)</td></tr><tr><td>519</td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna</td></tr><tr><td>520</td><td>COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech</td></tr><tr><td>521</td><td>COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK</td></tr><tr><td>231</td><td>influenza, Southern Hemisphere, high-dose, quadrivalent</td></tr><tr><td>303</td><td>RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF</td></tr><tr><td>304</td><td>Respiratory syncytial virus (RSV), unspecified</td></tr><tr><td>305</td><td>RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF</td></tr><tr><td>306</td><td>RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months</td></tr><tr><td>307</td><td>RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months</td></tr><tr><td>313</td><td>COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL</td></tr><tr><td>308</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL</td></tr><tr><td>309</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL</td></tr><tr><td>310</td><td>COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL</td></tr><tr><td>312</td><td>COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL</td></tr><tr><td>311</td><td>COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL</td></tr><tr><td>315</td><td>Respiratory syncytial virus (RSV) MAB, unspecified</td></tr><tr><td>314</td><td>Respiratory syncytial virus (RSV) vaccine, unspecified</td></tr><tr><td>316</td><td>Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</td></tr><tr><td>317</td><td>Chikungunya live attenuated vaccine, 0.5 mL, PF</td></tr><tr><td>318</td><td>Anthrax, post-exposure prophylaxis</td></tr><tr><td>319</td><td>Anthrax vaccine, unspecified</td></tr><tr><td>320</td><td>Influenza, MDCK, trivalent, preservative</td></tr><tr><td>321</td><td>Influenza-avian, H5N8, monovalent, PF</td></tr><tr><td>322</td><td>Influenza-avian, H5N8, monovalent, preservative</td></tr><tr><td>324</td><td>Poliovirus, inactivated, fractional-dose (fIPV)</td></tr><tr><td>323</td><td>Influenza-avian, H5, unspecified formulation</td></tr><tr><td>326</td><td>RSV, mRNA, injectable, PF</td></tr><tr><td>327</td><td>Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF</td></tr><tr><td>328</td><td>Meningococcal oligosaccharide (MenACWY), (MenB), PF</td></tr><tr><td>329</td><td>Chikungunya, VLP, recombinant, 0.8 mL, PF</td></tr><tr><td>330</td><td>Dengue fever, unspecified</td></tr><tr><td>331</td><td>Influenza, Southern Hemisphere, trivalent, PF</td></tr><tr><td>325</td><td>Vaccinia (smallpox, mpox), unspecified</td></tr><tr><td>332</td><td>RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF</td></tr><tr><td>333</td><td>Influenza, live, trivalent, intranasal, self/caregiver admin, PF</td></tr><tr><td>302</td><td>COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="pher"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="4">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"/>
</extension>
</valueInteger>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/shc-vaccination/ImplementationGuide/hl7.fhir.uv.shc-vaccination"/>
</extension>
</valueCode>
</extension>
<url
value="http://hl7.org/fhir/uv/shc-vaccination/ValueSet/immunization-all-cvx"/>
<version value="1.0.0"/>
<name value="ImmunizationAllCvxValueSet"/>
<title value="Immunization / All / CVX"/>
<status value="active"/>
<experimental value="false"/>
<date value="2025-09-03T20:15:06+00:00"/>
<publisher value="HL7 International / Public Health"/>
<contact>
<name value="HL7 International / Public Health"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/pher"/>
</telecom>
<telecom>
<system value="email"/>
<value value="vci-ig@mitre.org"/>
</telecom>
</contact>
<description
value="Contains all CVX codes from <https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx> as of 2025-09-03. This list of codes will not update automatically, so please refer to this URL for
the most up-to-date codes.the most up-to-date codes."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://hl7.org/fhir/sid/cvx"/>
<concept>
<code value="54"/>
<display value="adenovirus, type 4"/>
</concept>
<concept>
<code value="55"/>
<display value="adenovirus, type 7"/>
</concept>
<concept>
<code value="82"/>
<display value="adenovirus, unspecified formulation"/>
</concept>
<concept>
<code value="24"/>
<display
value="Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis"/>
</concept>
<concept>
<code value="19"/>
<display value="BCG"/>
</concept>
<concept>
<code value="27"/>
<display value="botulinum antitoxin"/>
</concept>
<concept>
<code value="26"/>
<display value="cholera, unspecified formulation"/>
</concept>
<concept>
<code value="29"/>
<display value="CMVIG"/>
</concept>
<concept>
<code value="56"/>
<display value="dengue fever tetravalent"/>
</concept>
<concept>
<code value="12"/>
<display value="diphtheria antitoxin"/>
</concept>
<concept>
<code value="28"/>
<display value="DT (pediatric)"/>
</concept>
<concept>
<code value="20"/>
<display value="DTaP"/>
</concept>
<concept>
<code value="106"/>
<display value="DTaP, 5 pertussis antigens"/>
</concept>
<concept>
<code value="107"/>
<display value="DTaP, unspecified formulation"/>
</concept>
<concept>
<code value="110"/>
<display value="DTaP-Hep B-IPV"/>
</concept>
<concept>
<code value="50"/>
<display value="DTaP-Hib"/>
</concept>
<concept>
<code value="120"/>
<display value="DTaP-Hib-IPV"/>
</concept>
<concept>
<code value="130"/>
<display value="DTaP-IPV"/>
</concept>
<concept>
<code value="22"/>
<display value="DTP-Hib"/>
</concept>
<concept>
<code value="102"/>
<display value="DTP-Hib-Hep B"/>
</concept>
<concept>
<code value="57"/>
<display value="hantavirus"/>
</concept>
<concept>
<code value="52"/>
<display value="Hep A, adult"/>
</concept>
<concept>
<code value="83"/>
<display value="Hep A, ped/adol, 2 dose"/>
</concept>
<concept>
<code value="84"/>
<display value="Hep A, ped/adol, 3 dose"/>
</concept>
<concept>
<code value="31"/>
<display value="Hep A, pediatric, unspecified formulation"/>
</concept>
<concept>
<code value="85"/>
<display value="Hep A, unspecified formulation"/>
</concept>
<concept>
<code value="104"/>
<display value="Hep A-Hep B"/>
</concept>
<concept>
<code value="30"/>
<display value="HBIG"/>
</concept>
<concept>
<code value="42"/>
<display value="Hep B, adolescent/high risk infant"/>
</concept>
<concept>
<code value="43"/>
<display value="Hep B, adult"/>
</concept>
<concept>
<code value="44"/>
<display value="Hep B, high-dosage, dialysis or IC"/>
</concept>
<concept>
<code value="45"/>
<display value="Hep B, unspecified formulation"/>
</concept>
<concept>
<code value="58"/>
<display value="Hep C"/>
</concept>
<concept>
<code value="59"/>
<display value="Hep E"/>
</concept>
<concept>
<code value="60"/>
<display value="herpes simplex 2"/>
</concept>
<concept>
<code value="46"/>
<display value="Hib (PRP-D)"/>
</concept>
<concept>
<code value="47"/>
<display value="Hib (HbOC)"/>
</concept>
<concept>
<code value="48"/>
<display value="Hib (PRP-T)"/>
</concept>
<concept>
<code value="49"/>
<display value="Hib (PRP-OMP)"/>
</concept>
<concept>
<code value="17"/>
<display value="Hib, unspecified formulation"/>
</concept>
<concept>
<code value="51"/>
<display value="Hib-Hep B"/>
</concept>
<concept>
<code value="61"/>
<display value="HIV"/>
</concept>
<concept>
<code value="118"/>
<display value="HPV, bivalent"/>
</concept>
<concept>
<code value="62"/>
<display value="HPV, quadrivalent"/>
</concept>
<concept>
<code value="86"/>
<display value="IG"/>
</concept>
<concept>
<code value="87"/>
<display value="IGIV"/>
</concept>
<concept>
<code value="14"/>
<display value="IG, unspecified formulation"/>
</concept>
<concept>
<code value="111"/>
<display value="Influenza, live, trivalent, intranasal, PF"/>
</concept>
<concept>
<code value="15"/>
<display value="influenza, split (incl. purified surface antigen)"/>
</concept>
<concept>
<code value="16"/>
<display value="influenza, whole"/>
</concept>
<concept>
<code value="88"/>
<display value="influenza, unspecified formulation"/>
</concept>
<concept>
<code value="123"/>
<display value="influenza, H5N1-1203"/>
</concept>
<concept>
<code value="10"/>
<display value="IPV"/>
</concept>
<concept>
<code value="89"/>
<display value="polio, unspecified formulation"/>
</concept>
<concept>
<code value="39"/>
<display value="Japanese encephalitis SC"/>
</concept>
<concept>
<code value="63"/>
<display value="Junin virus"/>
</concept>
<concept>
<code value="64"/>
<display value="leishmaniasis"/>
</concept>
<concept>
<code value="65"/>
<display value="leprosy"/>
</concept>
<concept>
<code value="66"/>
<display value="Lyme disease"/>
</concept>
<concept>
<code value="94"/>
<display value="MMRV"/>
</concept>
<concept>
<code value="67"/>
<display value="malaria"/>
</concept>
<concept>
<code value="68"/>
<display value="melanoma"/>
</concept>
<concept>
<code value="32"/>
<display value="meningococcal MPSV4"/>
</concept>
<concept>
<code value="103"/>
<display value="meningococcal C conjugate"/>
</concept>
<concept>
<code value="114"/>
<display value="meningococcal MCV4P"/>
</concept>
<concept>
<code value="108"/>
<display value="meningococcal ACWY, unspecified formulation"/>
</concept>
<concept>
<code value="69"/>
<display value="parainfluenza-3"/>
</concept>
<concept>
<code value="11"/>
<display value="pertussis"/>
</concept>
<concept>
<code value="23"/>
<display value="plague"/>
</concept>
<concept>
<code value="33"/>
<display value="pneumococcal polysaccharide PPV23"/>
</concept>
<concept>
<code value="100"/>
<display value="pneumococcal conjugate PCV 7"/>
</concept>
<concept>
<code value="109"/>
<display value="pneumococcal, unspecified formulation"/>
</concept>
<concept>
<code value="70"/>
<display value="Q fever"/>
</concept>
<concept>
<code value="18"/>
<display value="rabies, intramuscular injection"/>
</concept>
<concept>
<code value="40"/>
<display value="rabies, intradermal injection"/>
</concept>
<concept>
<code value="90"/>
<display value="rabies, unspecified formulation"/>
</concept>
<concept>
<code value="72"/>
<display value="rheumatic fever"/>
</concept>
<concept>
<code value="73"/>
<display value="Rift Valley fever"/>
</concept>
<concept>
<code value="34"/>
<display value="RIG"/>
</concept>
<concept>
<code value="119"/>
<display value="rotavirus, monovalent"/>
</concept>
<concept>
<code value="122"/>
<display value="rotavirus, unspecified formulation"/>
</concept>
<concept>
<code value="116"/>
<display value="rotavirus, pentavalent"/>
</concept>
<concept>
<code value="74"/>
<display value="rotavirus, tetravalent"/>
</concept>
<concept>
<code value="71"/>
<display value="RSV-IGIV"/>
</concept>
<concept>
<code value="93"/>
<display value="RSV-MAb"/>
</concept>
<concept>
<code value="38"/>
<display value="rubella/mumps"/>
</concept>
<concept>
<code value="76"/>
<display value="Staphylococcus bacterio lysate"/>
</concept>
<concept>
<code value="113"/>
<display
value="Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"/>
</concept>
<concept>
<code value="115"/>
<display value="Tdap"/>
</concept>
<concept>
<code value="35"/>
<display value="tetanus toxoid, adsorbed"/>
</concept>
<concept>
<code value="112"/>
<display value="tetanus toxoid, unspecified formulation"/>
</concept>
<concept>
<code value="77"/>
<display value="Tick-borne encephalitis vaccine (non-US)"/>
</concept>
<concept>
<code value="13"/>
<display value="TIG"/>
</concept>
<concept>
<code value="95"/>
<display value="TST-OT tine test"/>
</concept>
<concept>
<code value="96"/>
<display value="TST-PPD intradermal"/>
</concept>
<concept>
<code value="97"/>
<display value="TST-PPD tine test"/>
</concept>
<concept>
<code value="98"/>
<display value="TST, unspecified formulation"/>
</concept>
<concept>
<code value="78"/>
<display value="tularemia vaccine"/>
</concept>
<concept>
<code value="91"/>
<display value="typhoid, unspecified formulation"/>
</concept>
<concept>
<code value="25"/>
<display value="typhoid, oral"/>
</concept>
<concept>
<code value="41"/>
<display value="typhoid, parenteral"/>
</concept>
<concept>
<code value="53"/>
<display value="typhoid, parenteral, AKD (U.S. military)"/>
</concept>
<concept>
<code value="101"/>
<display value="typhoid, ViCPs"/>
</concept>
<concept>
<code value="75"/>
<display value="Vaccinia (smallpox, mpox), live"/>
</concept>
<concept>
<code value="105"/>
<display value="vaccinia (smallpox) diluted"/>
</concept>
<concept>
<code value="79"/>
<display value="vaccinia immune globulin"/>
</concept>
<concept>
<code value="21"/>
<display value="varicella"/>
</concept>
<concept>
<code value="81"/>
<display value="VEE, inactivated"/>
</concept>
<concept>
<code value="80"/>
<display value="VEE, live"/>
</concept>
<concept>
<code value="92"/>
<display value="VEE, unspecified formulation"/>
</concept>
<concept>
<code value="36"/>
<display value="VZIG"/>
</concept>
<concept>
<code value="117"/>
<display value="VZIG (IND)"/>
</concept>
<concept>
<code value="37"/>
<display value="yellow fever live"/>
</concept>
<concept>
<code value="121"/>
<display value="zoster live"/>
</concept>
<concept>
<code value="998"/>
<display value="no vaccine administered"/>
</concept>
<concept>
<code value="999"/>
<display value="unknown"/>
</concept>
<concept>
<code value="99"/>
<display value="RESERVED - do not use"/>
</concept>
<concept>
<code value="133"/>
<display value="Pneumococcal conjugate PCV 13"/>
</concept>
<concept>
<code value="134"/>
<display value="Japanese Encephalitis IM"/>
</concept>
<concept>
<code value="137"/>
<display value="HPV, unspecified formulation"/>
</concept>
<concept>
<code value="136"/>
<display value="Meningococcal MCV4O"/>
</concept>
<concept>
<code value="135"/>
<display value="Influenza, high-dose, trivalent, PF"/>
</concept>
<concept>
<code value="131"/>
<display value="typhus, historical"/>
</concept>
<concept>
<code value="132"/>
<display value="DTaP-IPV-HIB-HEP B, historical"/>
</concept>
<concept>
<code value="128"/>
<display value="Novel Influenza-H1N1-09, all formulations"/>
</concept>
<concept>
<code value="125"/>
<display value="Novel Influenza-H1N1-09, nasal"/>
</concept>
<concept>
<code value="126"/>
<display value="Novel influenza-H1N1-09, preservative-free"/>
</concept>
<concept>
<code value="127"/>
<display value="Novel influenza-H1N1-09"/>
</concept>
<concept>
<code value="138"/>
<display value="Td (adult)"/>
</concept>
<concept>
<code value="139"/>
<display value="Td(adult) unspecified formulation"/>
</concept>
<concept>
<code value="140"/>
<display value="Influenza, split virus, trivalent, PF"/>
</concept>
<concept>
<code value="129"/>
<display value="Japanese Encephalitis, unspecified formulation"/>
</concept>
<concept>
<code value="141"/>
<display value="Influenza, split virus, trivalent, preservative"/>
</concept>
<concept>
<code value="142"/>
<display value="tetanus toxoid, not adsorbed"/>
</concept>
<concept>
<code value="143"/>
<display value="Adenovirus types 4 and 7"/>
</concept>
<concept>
<code value="144"/>
<display value="influenza, seasonal, intradermal, preservative free"/>
</concept>
<concept>
<code value="145"/>
<display value="RSV-MAb (new)"/>
</concept>
<concept>
<code value="146"/>
<display value="DTaP,IPV,Hib,HepB"/>
</concept>
<concept>
<code value="147"/>
<display value="meningococcal MCV4, unspecified formulation"/>
</concept>
<concept>
<code value="148"/>
<display value="Meningococcal C/Y-HIB PRP"/>
</concept>
<concept>
<code value="149"/>
<display value="Influenza, live, quadrivalent, intranasal"/>
</concept>
<concept>
<code value="150"/>
<display value="Influenza, split virus, quadrivalent, PF"/>
</concept>
<concept>
<code value="151"/>
<display value="influenza nasal, unspecified formulation"/>
</concept>
<concept>
<code value="152"/>
<display value="Pneumococcal Conjugate, unspecified formulation"/>
</concept>
<concept>
<code value="153"/>
<display value="Influenza, MDCK, trivalent, PF"/>
</concept>
<concept>
<code value="154"/>
<display value="Hep A, IG"/>
</concept>
<concept>
<code value="155"/>
<display value="Influenza, recombinant, trivalent, PF"/>
</concept>
<concept>
<code value="156"/>
<display value="Rho(D)-IG"/>
</concept>
<concept>
<code value="157"/>
<display value="Rho(D) -IG IM"/>
</concept>
<concept>
<code value="158"/>
<display value="Influenza, split virus, quadrivalent, preservative"/>
</concept>
<concept>
<code value="159"/>
<display value="Rho(D) - Unspecified formulation"/>
</concept>
<concept>
<code value="160"/>
<display value="Influenza A monovalent (H5N1), ADJUVANTED-2013"/>
</concept>
<concept>
<code value="801"/>
<display value="AS03 Adjuvant"/>
</concept>
<concept>
<code value="161"/>
<display
value="Influenza, injectable,quadrivalent, preservative free, pediatric"/>
</concept>
<concept>
<code value="162"/>
<display value="meningococcal B, recombinant"/>
</concept>
<concept>
<code value="163"/>
<display value="meningococcal B, OMV"/>
</concept>
<concept>
<code value="164"/>
<display value="meningococcal B, unspecified"/>
</concept>
<concept>
<code value="165"/>
<display value="HPV9"/>
</concept>
<concept>
<code value="166"/>
<display
value="influenza, intradermal, quadrivalent, preservative free"/>
</concept>
<concept>
<code value="167"/>
<display value="meningococcal, unknown serogroups"/>
</concept>
<concept>
<code value="168"/>
<display value="Influenza, adjuvanted, trivalent, PF"/>
</concept>
<concept>
<code value="169"/>
<display value="Hep A, live attenuated"/>
</concept>
<concept>
<code value="170"/>
<display value="DTAP/IPV/HIB - non-US"/>
</concept>
<concept>
<code value="171"/>
<display value="Influenza, MDCK, quadrivalent, PF"/>
</concept>
<concept>
<code value="172"/>
<display value="cholera, WC-rBS"/>
</concept>
<concept>
<code value="173"/>
<display value="cholera, BivWC"/>
</concept>
<concept>
<code value="174"/>
<display value="cholera, live attenuated"/>
</concept>
<concept>
<code value="175"/>
<display value="Rabies - IM Diploid cell culture"/>
</concept>
<concept>
<code value="176"/>
<display value="Rabies - IM fibroblast culture"/>
</concept>
<concept>
<code value="177"/>
<display value="PCV10"/>
</concept>
<concept>
<code value="178"/>
<display value="OPV bivalent"/>
</concept>
<concept>
<code value="179"/>
<display value="OPV ,monovalent, unspecified"/>
</concept>
<concept>
<code value="180"/>
<display value="tetanus immune globulin"/>
</concept>
<concept>
<code value="181"/>
<display value="anthrax immune globulin"/>
</concept>
<concept>
<code value="182"/>
<display value="OPV, Unspecified"/>
</concept>
<concept>
<code value="183"/>
<display value="Yellow fever vaccine live - alt"/>
</concept>
<concept>
<code value="184"/>
<display value="Yellow fever, unspecified"/>
</concept>
<concept>
<code value="185"/>
<display value="Influenza, recombinant, quadrivalent, PF"/>
</concept>
<concept>
<code value="186"/>
<display value="Influenza, MDCK, quadrivalent, preservative"/>
</concept>
<concept>
<code value="187"/>
<display value="zoster recombinant"/>
</concept>
<concept>
<code value="188"/>
<display value="zoster, unspecified formulation"/>
</concept>
<concept>
<code value="189"/>
<display value="HepB-CpG"/>
</concept>
<concept>
<code value="190"/>
<display value="Typhoid conjugate vaccine (TCV)"/>
</concept>
<concept>
<code value="191"/>
<display value="meningococcal A polysaccharide (non-US)"/>
</concept>
<concept>
<code value="192"/>
<display value="meningococcal AC polysaccharide (non-US)"/>
</concept>
<concept>
<code value="193"/>
<display value="Hep A-Hep B, pediatric/adolescent"/>
</concept>
<concept>
<code value="194"/>
<display value="Influenza, Southern Hemisphere"/>
</concept>
<concept>
<code value="195"/>
<display value="DT, IPV adsorbed"/>
</concept>
<concept>
<code value="196"/>
<display
value="Td, adsorbed, preservative free, adult use, Lf unspecified"/>
</concept>
<concept>
<code value="197"/>
<display value="Influenza, high-dose, quadrivalent, PF"/>
</concept>
<concept>
<code value="200"/>
<display
value="influenza, Southern Hemisphere, pediatric, preservative free"/>
</concept>
<concept>
<code value="201"/>
<display value="Influenza, Southern Hemisphere, quadrivalent, PF"/>
</concept>
<concept>
<code value="202"/>
<display
value="influenza, Southern Hemisphere, quadrivalent, with preservative"/>
</concept>
<concept>
<code value="198"/>
<display value="DTP-hepB-Hib Pentavalent Non-US"/>
</concept>
<concept>
<code value="203"/>
<display
value="meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"/>
</concept>
<concept>
<code value="205"/>
<display value="Influenza, adjuvanted, quadrivalent, PF"/>
</concept>
<concept>
<code value="206"/>
<display
value="Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"/>
</concept>
<concept>
<code value="207"/>
<display
value="COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"/>
</concept>
<concept>
<code value="208"/>
<display value="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"/>
</concept>
<concept>
<code value="213"/>
<display value="SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"/>
</concept>
<concept>
<code value="210"/>
<display value="COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL"/>
</concept>
<concept>
<code value="212"/>
<display value="COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"/>
</concept>
<concept>
<code value="204"/>
<display value="Ebola Zaire vaccine, live, recombinant, 1mL dose"/>
</concept>
<concept>
<code value="214"/>
<display value="Ebola, unspecified"/>
</concept>
<concept>
<code value="211"/>
<display
value="COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"/>
</concept>
<concept>
<code value="500"/>
<display value="COVID-19 Non-US Vaccine, Product Unknown"/>
</concept>
<concept>
<code value="501"/>
<display value="COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"/>
</concept>
<concept>
<code value="502"/>
<display value="COVID-19 IV Non-US Vaccine (COVAXIN)"/>
</concept>
<concept>
<code value="503"/>
<display value="COVID-19 LAV Non-US Vaccine (COVIVAC)"/>
</concept>
<concept>
<code value="504"/>
<display value="COVID-19 VVnr Non-US Vaccine (Sputnik Light)"/>
</concept>
<concept>
<code value="505"/>
<display value="COVID-19 VVnr Non-US Vaccine (Sputnik V)"/>
</concept>
<concept>
<code value="506"/>
<display
value="COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"/>
</concept>
<concept>
<code value="507"/>
<display
value="COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"/>
</concept>
<concept>
<code value="508"/>
<display
value="COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"/>
</concept>
<concept>
<code value="509"/>
<display value="COVID-19 PS Non-US Vaccine (EpiVacCorona)"/>
</concept>
<concept>
<code value="510"/>
<display value="COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"/>
</concept>
<concept>
<code value="511"/>
<display value="COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"/>
</concept>
<concept>
<code value="215"/>
<display
value="Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"/>
</concept>
<concept>
<code value="216"/>
<display
value="Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"/>
</concept>
<concept>
<code value="219"/>
<display
value="COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"/>
</concept>
<concept>
<code value="217"/>
<display
value="COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"/>
</concept>
<concept>
<code value="218"/>
<display
value="COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"/>
</concept>
<concept>
<code value="220"/>
<display value="HepB recombinant, 3-antigen, Al(OH)3"/>
</concept>
<concept>
<code value="221"/>
<display value="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"/>
</concept>
<concept>
<code value="222"/>
<display value="Tick-borne encephalitis, unspecified"/>
</concept>
<concept>
<code value="223"/>
<display value="Tick-borne encephalitis, inactivated, PF, 0.25mL"/>
</concept>
<concept>
<code value="224"/>
<display value="Tick-borne encephalitis, inactivated, PF, 0.5mL"/>
</concept>
<concept>
<code value="225"/>
<display
value="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"/>
</concept>
<concept>
<code value="226"/>
<display
value="COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"/>
</concept>
<concept>
<code value="512"/>
<display
value="SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"/>
</concept>
<concept>
<code value="513"/>
<display
value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"/>
</concept>
<concept>
<code value="514"/>
<display
value="SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"/>
</concept>
<concept>
<code value="515"/>
<display
value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"/>
</concept>
<concept>
<code value="516"/>
<display
value="COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"/>
</concept>
<concept>
<code value="517"/>
<display
value="SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"/>
</concept>
<concept>
<code value="227"/>
<display
value="COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"/>
</concept>
<concept>
<code value="228"/>
<display
value="COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"/>
</concept>
<concept>
<code value="229"/>
<display
value="COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"/>
</concept>
<concept>
<code value="301"/>
<display
value="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"/>
</concept>
<concept>
<code value="300"/>
<display
value="COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"/>
</concept>
<concept>
<code value="230"/>
<display value="COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"/>
</concept>
<concept>
<code value="518"/>
<display
value="COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"/>
</concept>
<concept>
<code value="519"/>
<display
value="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"/>
</concept>
<concept>
<code value="520"/>
<display
value="COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"/>
</concept>
<concept>
<code value="521"/>
<display
value="COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"/>
</concept>
<concept>
<code value="231"/>
<display
value="influenza, Southern Hemisphere, high-dose, quadrivalent"/>
</concept>
<concept>
<code value="303"/>
<display
value="RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"/>
</concept>
<concept>
<code value="304"/>
<display value="Respiratory syncytial virus (RSV), unspecified"/>
</concept>
<concept>
<code value="305"/>
<display
value="RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"/>
</concept>
<concept>
<code value="306"/>
<display
value="RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"/>
</concept>
<concept>
<code value="307"/>
<display
value="RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"/>
</concept>
<concept>
<code value="313"/>
<display
value="COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"/>
</concept>
<concept>
<code value="308"/>
<display
value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"/>
</concept>
<concept>
<code value="309"/>
<display
value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"/>
</concept>
<concept>
<code value="310"/>
<display
value="COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"/>
</concept>
<concept>
<code value="312"/>
<display value="COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"/>
</concept>
<concept>
<code value="311"/>
<display value="COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"/>
</concept>
<concept>
<code value="315"/>
<display value="Respiratory syncytial virus (RSV) MAB, unspecified"/>
</concept>
<concept>
<code value="314"/>
<display
value="Respiratory syncytial virus (RSV) vaccine, unspecified"/>
</concept>
<concept>
<code value="316"/>
<display
value="Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF"/>
</concept>
<concept>
<code value="317"/>
<display value="Chikungunya live attenuated vaccine, 0.5 mL, PF"/>
</concept>
<concept>
<code value="318"/>
<display value="Anthrax, post-exposure prophylaxis"/>
</concept>
<concept>
<code value="319"/>
<display value="Anthrax vaccine, unspecified"/>
</concept>
<concept>
<code value="320"/>
<display value="Influenza, MDCK, trivalent, preservative"/>
</concept>
<concept>
<code value="321"/>
<display value="Influenza-avian, H5N8, monovalent, PF"/>
</concept>
<concept>
<code value="322"/>
<display value="Influenza-avian, H5N8, monovalent, preservative"/>
</concept>
<concept>
<code value="324"/>
<display value="Poliovirus, inactivated, fractional-dose (fIPV)"/>
</concept>
<concept>
<code value="323"/>
<display value="Influenza-avian, H5, unspecified formulation"/>
</concept>
<concept>
<code value="326"/>
<display value="RSV, mRNA, injectable, PF"/>
</concept>
<concept>
<code value="327"/>
<display
value="Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF"/>
</concept>
<concept>
<code value="328"/>
<display value="Meningococcal oligosaccharide (MenACWY), (MenB), PF"/>
</concept>
<concept>
<code value="329"/>
<display value="Chikungunya, VLP, recombinant, 0.8 mL, PF"/>
</concept>
<concept>
<code value="330"/>
<display value="Dengue fever, unspecified"/>
</concept>
<concept>
<code value="331"/>
<display value="Influenza, Southern Hemisphere, trivalent, PF"/>
</concept>
<concept>
<code value="325"/>
<display value="Vaccinia (smallpox, mpox), unspecified"/>
</concept>
<concept>
<code value="332"/>
<display
value="RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF"/>
</concept>
<concept>
<code value="333"/>
<display
value="Influenza, live, trivalent, intranasal, self/caregiver admin, PF"/>
</concept>
<concept>
<code value="302"/>
<display
value="COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2021+ HL7 International / Public Health. Package hl7.fhir.uv.shc-vaccination#1.0.0 based on FHIR 4.0.1. Generated 2025-09-03
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change